v3.19.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current Assets    
Cash $ 56,023 $ 50,903
Advance to vendor 86,149 86,149
Prepaid assets 5,846 16,457
Accounts receivable 62,256 45,818
Total Current Assets 210,274 199,327
Office equipment, net 6,400 7,199
Goodwill 239,151 239,151
License Rights 203,125 213,542
TOTAL ASSETS 658,950 659,219
Current Liabilities    
Accounts payable and accrued expenses 389,940 298,319
Accounts payable and accrued expenses, related parties 530,117 552,806
Convertible notes payable, net of discounts 733,958 514,102
Convertible note payable, related party 50,000 50,000
Notes Payable 332,838 332,838
Notes Payable, related party 60,000 60,000
Derivative liabilities 1,268,477 1,199,514
Total Current Liabilities 3,365,330 3,007,579
Stockholders' Deficit    
Preferred stock (10,000,000 shares authorized, par value $0.001, no shares issued and outstanding)
Common stock (290,000,000 shares authorized par value $0.001, 29,630,445 and 29,068,202 shares issued and outstanding March 31, 2019 and December 31, 2018, respectively) 29,631 29,069
Deferred stock compensation (295,547) (269,167)
Common stock to be issued (450,000 shares issuable March 31, 2019) 450 0
Additional paid in capital 2,531,174 1,959,857
Accumulated Deficit (4,972,903) (4,068,747)
Stock subscription receivable (7,600) (7,600)
Accumulated comprehensive gain 8,415 8,228
Total Stockholders' Deficit (2,706,380) (2,348,360)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 658,950 $ 659,219

Source